News from all angles
(MedPage Today) -- An adjuvant personalized DNA vaccine was safe and demonstrated promising efficacy among patients with MGMT-unmethylated glioblastoma in a phase I trial. The vaccine caused no serio…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network